PRELUDE CAPITAL MANAGEMENT, LLC - SYNERON MEDICAL LTD ownership

SYNERON MEDICAL LTD's ticker is ELOS and the CUSIP is M87245102. A total of 4 filers reported holding SYNERON MEDICAL LTD in Q3 2017. The put-call ratio across all filers is - and the average weighting 23.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of SYNERON MEDICAL LTD
ValueSharesWeighting
Q2 2017$1,258,000
+364.2%
114,926
+346.6%
0.12%
+357.7%
Q1 2017$271,000
-8.1%
25,731
-26.7%
0.03%
-27.8%
Q4 2016$295,000
+656.4%
35,112
+550.2%
0.04%
+800.0%
Q3 2016$39,000
+18.2%
5,400
+25.6%
0.00%
-20.0%
Q2 2016$33,000
+83.3%
4,300
+73.0%
0.01%
+66.7%
Q1 2016$18,000
-60.0%
2,486
-31.2%
0.00%
-50.0%
Q1 2015$45,0003,6160.01%
Other shareholders
SYNERON MEDICAL LTD shareholders Q3 2017
NameSharesValueWeighting ↓
NORTH TIDE CAPITAL, LLC 3,000,000$31,650,0004.86%
Discovery Group I, LLC 1,221,310$12,885,0004.30%
Kenmare Capital Partners, L.L.C. 389,177$4,106,0003.98%
Profit Investment Management, LLC 237,217$2,503,0002.03%
Senvest Management, LLC 2,202,272$23,234,0001.66%
PERRITT CAPITAL MANAGEMENT INC 426,370$4,498,0001.14%
Camber Capital Management LP 2,347,593$24,767,0001.00%
DALTON GREINER HARTMAN MAHER & CO 1,645,048$17,355,0000.99%
Lapides Asset Management, LLC 396,800$4,186,0000.78%
DAFNA Capital Management LLC 85,947$907,0000.77%
View complete list of SYNERON MEDICAL LTD shareholders